PD Dr. Alessandra Curioni-Fontecedro, UniversitätsSpital Zürich

Comment on 1287PD - Preoperative chemotherapy and radiotherapy concomitant to cetuximab in stage IIIB NSCLC: A multicenter phase II SAKK Study: